Showing results (1-10 of 13) with videos related to
Sort By:
Pageof 2
Cancer|May 24, 2014
Ambulatory cancer and US general population reference values and cutoff scores for the functional assessment of cancer therapyTimothy Pearman, Betina Yanez, John Peipert, et al.Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|October 30, 2014
Brief versions of the FACIT-fatigue and FAACT subscales for patients with non-small cell lung cancer cachexiaJohn M Salsman, Jennifer L Beaumont, Katy Wortman, et al.Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|June 15, 2011
Examining web equivalence and risk factor sensitivity of the COPD population screenerJennifer L Beaumont, David Victorson, Jun Su, et al.Epilepsy & Behavior : E&B|April 12, 2015
Validation of the Neuro-QoL measurement system in children with epilepsyJin-Shei Lai, Cindy J Nowinski, Frank Zelko, et al.Cancer|August 3, 2019
Implementing electronic health record-integrated screening of patient-reported symptoms and supportive care needs in a comprehensive cancer centerSofia F Garcia, Katy Wortman, David Cella, et al.Journal of Adolescent and Young Adult Oncology|December 10, 2019
Piloting a Survivorship Screening Tool in a Specialty Clinic for Survivors of Childhood CancersAllison P Fisher, Katy Wortman, Karen Kinahan, et al.Lung|February 11, 2016
Health-Related Quality of Life in Patients with Idiopathic Pulmonary FibrosisSusan E Yount, Jennifer L Beaumont, Shih-Yin Chen, et al.Multiple Sclerosis (Houndmills, Basingstoke, England)|August 5, 2015
Validating Neuro-QoL short forms and targeted scales with people who have multiple sclerosisDeborah M Miller, Francois Bethoux, David Victorson, et al.Contemporary Clinical Trials Communications|March 7, 2022
Rationale and usability findings of an e-health intervention to improve oral anticancer adherence among breast cancer survivors: The My Journey mindfulness studyBetina Yanez, Laura B Oswald, Alyssa N Van Denburg, et al.British Journal of Haematology|October 16, 2014
Phase I/II trial of vorinostat with rituximab, cyclophosphamide, etoposide and prednisone as palliative treatment for elderly patients with relapsed or refractory diffuse large B-cell lymphoma not eligible for autologous stem cell transplantationDavid J Straus, Paul A Hamlin, Matthew J Matasar, et al.Pageof 2